We recently published a list of 15 best shares to buy according to Jim Simons Renaissance technologies In this article, let’s take a look at On United Therapeutics Corporation (NASDAQ: UTHR) is against other better actions to buy according to Renaissance technologies by Jim Simons.
Even after its passage in 2024, the investor and mathematician billionaire Jim Simons is still known as the “King How much” in coverage funds due to the extraordinary success of Renaissance technologiesYour quantitative negotiation company based in New York. After years of financial industry research, Simons realized the potential without exploiting quantitative analyzes to take advantage of market inefficiencies. This vision led him to develop an investment strategy based on data to analyze market behavior only through statistical and mathematical models. By identifying the subtle patterns and not random in financial data, the genius as much predicted future movements of the actions and generated impressive returns.
Although closed to external investors, the secret fund of the medallion of Jim Simons, a Renaissance flagship, has produced innovative results since its inception. The Medallion Fund gained impressive returns of 56.6% and 74.6% during the first Dot-Compe accident in the early 2000’s and the world financial crisis between 2007 and 2011. The fund has maintained a substantial annual return of 31.5% since its first two years of operation. At the time of his death, Simons was worth $ 31.4 billion, placing it among the richest individuals in the world, thanks to the strong performance of the Market Market Medallion and Renaissance.
The Renaissance Technologies computer based power plant began to begin after stellar realization in 2024. The Renaissance diversified Alpha Fund 11.85% in the first two months of 2025. Both funds can maintain important positions of individual stock, as well as use future actions index and options to help manage the risk. However, the firm warns that it may be difficult to quickly undo these important stakes without affecting market prices.
For this list, we have chosen actions of the Renaissance Technologies 13f portfolio in the late quarter of 2024. These actions are also popular with elite coverage funds.
Why are we interested in the stocks that cover the funds? The reason is simple: our research has shown that we can overcome the market by imitating the best stock options for the best coverage funds. The strategy of our quarterly bulletin selects 14 stocks of small layers and large layers each quarter and has returned 373.4% since May 2014, surpassing its reference point at 218 percentage points (Check out more details here)).
Is United Therapeutics Corporation (Uthr) the best stock to buy according to Jim Simons Renaissance technologies?
A team of scientists in a laboratory, trying tests on a biotechnology product.
Renaissance Technologies Q4 bet: $ 737.2 million
Number of coverage fund holders: 42
United Therapeutics Corporation (NASDAQ: UTHR) is a biotechnology company that develops and manufactures replacements and treatments for organ disorders. The three primary drugs of the company, Tyvaso, Orenitram and remoduling, are aimed at patients, hospitals and specialized pharmacies.
TD Cowen reiterated his purchase rating from United Therapeutics Corporation (NASDAQ: Uthr) on May 7, quoting a stable price goal of $ 400. The guarantee follows a recent meeting with the company’s management, which took place after its call for the results for the first quarter. TD Cowen analysts stated that management discussed the continuous introduction of Tyvaso PH-Tim and expressed confidence in the drug’s ability to treat idopathic pulmonary fibrosis (IPF), with preliminary results provided in the second half of the year.
United Therapeutics Corporation (NASDAQ: UTHR) exceeded market expectations with its first quarter of 2025 financial performance. The company reported $ 6.63, exceeding $ 6.53 and reached record income of $ 794.4 million, significantly more than $ 728.34 million. The strong demand for its Treprostinil product lines, including Tyvaso and remodeling, contributed to an increase in revenue of 17% year -on -year.
Usually uthr Ranks 2nd In our list of best shares to buy according to Renaissance technologies by Jim Simons. Although we recognize Uthr’s potential as an investment, our conviction lies in the belief that some AI actions have a greater promise to obtain higher yields and do it in a shorter period. There is an AI stock that increased since the beginning of 2025, while the popular AI actions lost around 25%. If you are looking for a stock of Ia more promising than Uthr but sells less than five times, see our report on this Ia stock cheap.
